Enhanced <i>Clostridioides difficile</i> Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain <i>Lactobacillus</i> Probiotic Concomitantly to Antibiotic Therapy
Pierre-Jean Maziade, Noam Ship, Jason Sniffen, Ellie J. C. Goldstein
Abstract
When 70% of antibiotic users took a 3-strain Lactobacillus probiotic preparation the hospital-wide rate of healthcare-associated Clostridioides difficile infection improved significantly. The incidence of C. difficile infection for those taking the probiotic along with multiple antibiotics or a single high-risk antibiotic was decreased by at least half.
Topics & Concepts
ClostridioidesProbioticMedicineAntibioticsAntibiotic-associated diarrheaLactobacillusMicrobiologyAntibiotic therapyIncidence (geometry)PharmacyClostridium difficileInternal medicineBacteriaBiologyNursingOpticsGeneticsPhysicsClostridium difficile and Clostridium perfringens researchMicroscopic ColitisViral gastroenteritis research and epidemiology